{Reference Type}: Journal Article
{Title}: Sarcopenia in the Cirrhotic Patient: Current Knowledge and Future Directions.
{Author}: Warner Ii ER;Satapathy SK;
{Journal}: J Clin Exp Hepatol
{Volume}: 13
{Issue}: 1
{Year}: Jan-Feb 2023
暂无{DOI}: 10.1016/j.jceh.2022.06.005
{Abstract}: Cirrhosis predisposes to abnormalities in energy, hormonal, and immunological homeostasis. Disturbances in these metabolic processes create susceptibility to sarcopenia or pathological muscle wasting. Sarcopenia is prevalent in cirrhosis and its presence portends significant adverse outcomes including the length of hospital stay, infectious complications, and mortality. This highlights the importance of identification of at-risk individuals with early nutritional, therapeutic and physical therapy intervention. This manuscript summarizes literature relevant to sarcopenia in cirrhosis, describes current knowledge, and elucidates possible future directions.